user_variable,user_description,matched_text,uid,relevance_score
submitter_id,A project-specific identifier for a node. This property is the calling card/nickname/alias for a unit of submission. It can be used in place of the UUID for identifying or recalling a node.,UNIQUE COMMUNITY IDENTIFIER,242980,0.33884242
submitter_id,A project-specific identifier for a node. This property is the calling card/nickname/alias for a unit of submission. It can be used in place of the UUID for identifying or recalling a node.,UNIQUE SUBJECT ID,242989,0.26683462
submitter_id,A project-specific identifier for a node. This property is the calling card/nickname/alias for a unit of submission. It can be used in place of the UUID for identifying or recalling a node.,UNIQUE SUBJECT IDENTIFIER,242990,0.26435837
participant_id,Unique identifier that can be used to retrieve more information for a participant.,PARTICIPANT IDENTIFICATION,177036,0.94407386
participant_id,Unique identifier that can be used to retrieve more information for a participant.,PARTICIPANT ID,177033,0.9413314
participant_id,Unique identifier that can be used to retrieve more information for a participant.,PARTICIPANT ID NUMBER,177035,0.8513359
consent_codes,"Data Use Restrictions that are used to indicate permissions/restrictions for datasets and/or materials, and relates to the purposes for which datasets and/or material might be removed, stored or used.Based on the Data Use Ontology : see http://www.obofoundry.org/ontology/duo.htmlGRU - For general research use for any research purpose. Example of usage: This includes but is not limited to: health/medical/biomedical purposes, fundamental biology research, the study of population origins or ancestry, statistical methods and algorithms development, and social-sciences research.HMB - Use of the data is limited to health/medical/biomedical purposes; does not include the study of population origins or ancestry.DS-X - Use of the data must be related to [disease].NPU - Use of the data is limited to not-for-profit organizations and not-for-profit use, non-commercial use.IRB - Requestor must provide documentation of local IRB/REC approval.",PERMISSION FOR NON-PROFIT USE OF DATA,180823,0.9804313
consent_codes,"Data Use Restrictions that are used to indicate permissions/restrictions for datasets and/or materials, and relates to the purposes for which datasets and/or material might be removed, stored or used.Based on the Data Use Ontology : see http://www.obofoundry.org/ontology/duo.htmlGRU - For general research use for any research purpose. Example of usage: This includes but is not limited to: health/medical/biomedical purposes, fundamental biology research, the study of population origins or ancestry, statistical methods and algorithms development, and social-sciences research.HMB - Use of the data is limited to health/medical/biomedical purposes; does not include the study of population origins or ancestry.DS-X - Use of the data must be related to [disease].NPU - Use of the data is limited to not-for-profit organizations and not-for-profit use, non-commercial use.IRB - Requestor must provide documentation of local IRB/REC approval.",ANY PERMISSION FOR USE - NON-GENETIC DATA,21660,0.9795506
consent_codes,"Data Use Restrictions that are used to indicate permissions/restrictions for datasets and/or materials, and relates to the purposes for which datasets and/or material might be removed, stored or used.Based on the Data Use Ontology : see http://www.obofoundry.org/ontology/duo.htmlGRU - For general research use for any research purpose. Example of usage: This includes but is not limited to: health/medical/biomedical purposes, fundamental biology research, the study of population origins or ancestry, statistical methods and algorithms development, and social-sciences research.HMB - Use of the data is limited to health/medical/biomedical purposes; does not include the study of population origins or ancestry.DS-X - Use of the data must be related to [disease].NPU - Use of the data is limited to not-for-profit organizations and not-for-profit use, non-commercial use.IRB - Requestor must provide documentation of local IRB/REC approval.",PERMISSION FOR FOR-PROFIT USE OF DATA,180821,0.97923523
amputation_type,"If amputated, the amputation type for leg, above the knee or below the knee.  ","13B2. LOWER EXTREMITY AMPUTATION (TOE, FOREFOOT, HEEL, BELOW THE KNEE)",4733,0.8856315
amputation_type,"If amputated, the amputation type for leg, above the knee or below the knee.  ",AMPUTATION OF LOWER EXTREMITY,19693,0.23231015
amputation_type,"If amputated, the amputation type for leg, above the knee or below the knee.  ",AMPUTATION,19692,0.1183851
cohort_id,"The study subgroup that the participant belongs to. This indicates whether the participant was a postmortem donor, an organ donor, or a surgical donor.  ",DONOR BLOOD GROUP,75719,0.6977119
cohort_id,"The study subgroup that the participant belongs to. This indicates whether the participant was a postmortem donor, an organ donor, or a surgical donor.  ",DERIVED DUPLICATE DONOR RECIPIENT (BASED ON DONOR'S STUDY ARM AND RECIPIENT),68680,0.45259643
cohort_id,"The study subgroup that the participant belongs to. This indicates whether the participant was a postmortem donor, an organ donor, or a surgical donor.  ","SUBJECT RECEIVED A STUDY TRANSPLANT (0=NO, 1=YES)",226487,0.3455468
data_submission_guid,"A Globally Unique IDentifier (GUID) provided by the data submitter, used to identify this subject across multiple projects, commons, etc.",UNIQUE SUBJECT IDENTIFIER,242990,0.9619649
data_submission_guid,"A Globally Unique IDentifier (GUID) provided by the data submitter, used to identify this subject across multiple projects, commons, etc.",UNIQUE SUBJECT ID,242989,0.8098782
data_submission_guid,"A Globally Unique IDentifier (GUID) provided by the data submitter, used to identify this subject across multiple projects, commons, etc.",PUBLIC SUBJECT ID,189115,0.66235983
derived_parent_subject_id,Unique subject identifier associated with parent project; derived from parent accession and submitted subject ID.,UNIQUE SUBJECT IDENTIFIER,242990,0.97622
derived_parent_subject_id,Unique subject identifier associated with parent project; derived from parent accession and submitted subject ID.,UNIQUE SUBJECT ID,242989,0.951504
derived_parent_subject_id,Unique subject identifier associated with parent project; derived from parent accession and submitted subject ID.,SUBJECT ID,226431,0.78282857
derived_topmed_subject_id,Unique subject identifier associated with TOPMed project; derived from TOPMed accession and submitted subject ID.,UNIQUE SUBJECT IDENTIFIER,242990,0.9887988
derived_topmed_subject_id,Unique subject identifier associated with TOPMed project; derived from TOPMed accession and submitted subject ID.,UNIQUE SUBJECT ID,242989,0.97520185
derived_topmed_subject_id,Unique subject identifier associated with TOPMed project; derived from TOPMed accession and submitted subject ID.,DEIDENTIFIED DERIVED PATIENT ID,68150,0.7210563
eligibility,A verification field of whether the Donor has met the overall eligibility criteria for GTEx collection based on answers to eligibility questions. All Eligibility conditions require confirmation from the donor procurement team (staff team where tissue collection and data abstraction takes place) and must be met in order for donor to eligible.  ,ELIGIBILITY VERIFICATION,81775,0.94957596
eligibility,A verification field of whether the Donor has met the overall eligibility criteria for GTEx collection based on answers to eligibility questions. All Eligibility conditions require confirmation from the donor procurement team (staff team where tissue collection and data abstraction takes place) and must be met in order for donor to eligible.  ,DONOR MEETS INCL CRITERIA,75867,0.94122344
eligibility,A verification field of whether the Donor has met the overall eligibility criteria for GTEx collection based on answers to eligibility questions. All Eligibility conditions require confirmation from the donor procurement team (staff team where tissue collection and data abstraction takes place) and must be met in order for donor to eligible.  ,GD01: D3. DOES DONOR MEET STANDARD BLOOD CENTER CRITERIA,102932,0.82810634
geographic_site,"""Site where the subject was recruted. ARIC_A=field center A representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), ARIC_B=field center B representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), ARIC_C=field center C representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), ARIC_D=field center D representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), CARDIA_1=field center 1 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CARDIA_2=field center 2 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CARDIA_3=field center 3 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CARDIA_4=field center 4 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CHS_BOWMAN.GRAY=clinic at Bowman Gray University (Forsyth County, NC, USA) for CHS (Cardiovascular Health Study), CHS_DAVIS=clinic at Davis University (Sacramento County, CA, USA) for CHS (Cardiovascular Health Study), CHS_HOPKINS=clinic at Johns Hopkins University (Washington County, MD, USA) for CHS (Cardiovascular Health Study), CHS_PITT=clinic at University of Pittsburgh (Pittsburgh, PA, USA) for CHS (Cardiovascular Health Study), COPDGene_C01=clinical center C01 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C02=clinical center C02 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C03=clinical center C03 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C04=clinical center C04 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C05=clinical center C05 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C06=clinical center C06 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C07=clinical center C07 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C08=clinical center C08 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C09=clinical center C09 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C10=clinical center C10 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C11=clinical center C11 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C12=clinical center C12 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C13=clinical center C13 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C14=clinical center C14 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C15=clinical center C15 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C16=clinical center C16 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C17=clinical center C17 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C18=clinical center C18 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C19=clinical center C19 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C20=clinical center C20 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C21=clinical center C21 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), GENOA_MN=recruitment from Rochester, MN, US, GENOA_MS=recruitment from Jackson, MS, US, GOLDN_MN=recruitment center at Minneapolis, MN, USA for GOLDN (Genetics of Lipid Lowering Drugs and Diet Network Lipodemics Study), GOLDN_UT=recruitment center at Salt Lake City, UT, USA for GOLDN (Genetics of Lipid Lowering Drugs and Diet Network Lipodemics Study), HCHS_SOL_Bronx=recruitment center Bronx, NY, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), HCHS_SOL_Chicago=recruitment center Chicago, IL, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), HCHS_SOL_Miami=recruitment center Miami, FL, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), HCHS_SOL_SanDiego=recruitment center San Diego, CA, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), JHS_Hinds=recruitment from urban and rural areas of Hinds county, MS, USA for JHS (Jackson Heart Study), JHS_Madison=recruitment from urban and rural areas of Madison county, MS, USA for JHS (Jackson Heart Study), JHS_Rankin=recruitment from urban and rural areas of Rankin county, MS, USA for JHS (Jackson Heart Study), JHS_Unknown=recruitment from unknown county in MS, USA for JHS (Jackson Heart Study), Mayo_VTE_Midwest_US=state of residence (at time of enrollment for Mayo_VTE study) is in the South region of the USA as defined by the Census Bureau, Mayo_VTE_Northeast_US=state of residence (at time of enrollment for Mayo_VTE study) is in the Northeast region of the USA as defined by the Census Bureau, Mayo_VTE_non_US=state of residence (at time of enrollment for Mayo_VTE study) is from a country outside the USA, Mayo_VTE_South_US=state of residence (at time of enrollment for Mayo_VTE study) is in the Midwest region of the USA as defined by the Census Bureau, Mayo_VTE_West_US=state of residence (at time of enrollment for Mayo_VTE study) is in the West region of the USA as defined by the Census Bureau, MESA_COL=field center/baseline clinic at Columbia University, NY, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_JHU=field center/baseline clinic at Johns Hopkins University, MD, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_NWU=field center/baseline clinic at Northwestern University, IL, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_UCLA=field center/baseline clinic at University of California, Los Angeles, CA, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_UMN=field center/baseline clinic at University of Minnesota, MN, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_WFU=field center/baseline clinic at Wake Forest University, NC, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), SAS_Apia.urban=recruitment census region of Apia Urban Area in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), SAS_NW.Upola=recruitment census region of Northwest Upola in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), SAS_rest.Upola=recruitment census region including rest of Upola in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), SAS_Savaii=recruitment census region of Savaii in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), WHI_Midwest=recruitment from Midwest region of the USA for WHI (Womens Health Initiative), WHI_Northeast=recruitment from Northeast region of the USA for WHI (Womens Health Initiative), WHI_South=recruitment from South region of the USA for WHI (Womens Health Initiative), WHI_West=recruitment from West region of the USA for WHI (Womens Health Initiative)"" (HARMONIZED)",IS PATIENT ADDRESS IN ARIC COMMUNITY SURVEILLANCE CATCHMENT AREA? Q5B,127229,0.34543642
geographic_site,"""Site where the subject was recruted. ARIC_A=field center A representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), ARIC_B=field center B representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), ARIC_C=field center C representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), ARIC_D=field center D representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), CARDIA_1=field center 1 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CARDIA_2=field center 2 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CARDIA_3=field center 3 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CARDIA_4=field center 4 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CHS_BOWMAN.GRAY=clinic at Bowman Gray University (Forsyth County, NC, USA) for CHS (Cardiovascular Health Study), CHS_DAVIS=clinic at Davis University (Sacramento County, CA, USA) for CHS (Cardiovascular Health Study), CHS_HOPKINS=clinic at Johns Hopkins University (Washington County, MD, USA) for CHS (Cardiovascular Health Study), CHS_PITT=clinic at University of Pittsburgh (Pittsburgh, PA, USA) for CHS (Cardiovascular Health Study), COPDGene_C01=clinical center C01 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C02=clinical center C02 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C03=clinical center C03 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C04=clinical center C04 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C05=clinical center C05 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C06=clinical center C06 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C07=clinical center C07 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C08=clinical center C08 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C09=clinical center C09 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C10=clinical center C10 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C11=clinical center C11 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C12=clinical center C12 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C13=clinical center C13 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C14=clinical center C14 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C15=clinical center C15 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C16=clinical center C16 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C17=clinical center C17 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C18=clinical center C18 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C19=clinical center C19 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C20=clinical center C20 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C21=clinical center C21 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), GENOA_MN=recruitment from Rochester, MN, US, GENOA_MS=recruitment from Jackson, MS, US, GOLDN_MN=recruitment center at Minneapolis, MN, USA for GOLDN (Genetics of Lipid Lowering Drugs and Diet Network Lipodemics Study), GOLDN_UT=recruitment center at Salt Lake City, UT, USA for GOLDN (Genetics of Lipid Lowering Drugs and Diet Network Lipodemics Study), HCHS_SOL_Bronx=recruitment center Bronx, NY, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), HCHS_SOL_Chicago=recruitment center Chicago, IL, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), HCHS_SOL_Miami=recruitment center Miami, FL, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), HCHS_SOL_SanDiego=recruitment center San Diego, CA, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), JHS_Hinds=recruitment from urban and rural areas of Hinds county, MS, USA for JHS (Jackson Heart Study), JHS_Madison=recruitment from urban and rural areas of Madison county, MS, USA for JHS (Jackson Heart Study), JHS_Rankin=recruitment from urban and rural areas of Rankin county, MS, USA for JHS (Jackson Heart Study), JHS_Unknown=recruitment from unknown county in MS, USA for JHS (Jackson Heart Study), Mayo_VTE_Midwest_US=state of residence (at time of enrollment for Mayo_VTE study) is in the South region of the USA as defined by the Census Bureau, Mayo_VTE_Northeast_US=state of residence (at time of enrollment for Mayo_VTE study) is in the Northeast region of the USA as defined by the Census Bureau, Mayo_VTE_non_US=state of residence (at time of enrollment for Mayo_VTE study) is from a country outside the USA, Mayo_VTE_South_US=state of residence (at time of enrollment for Mayo_VTE study) is in the Midwest region of the USA as defined by the Census Bureau, Mayo_VTE_West_US=state of residence (at time of enrollment for Mayo_VTE study) is in the West region of the USA as defined by the Census Bureau, MESA_COL=field center/baseline clinic at Columbia University, NY, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_JHU=field center/baseline clinic at Johns Hopkins University, MD, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_NWU=field center/baseline clinic at Northwestern University, IL, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_UCLA=field center/baseline clinic at University of California, Los Angeles, CA, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_UMN=field center/baseline clinic at University of Minnesota, MN, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_WFU=field center/baseline clinic at Wake Forest University, NC, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), SAS_Apia.urban=recruitment census region of Apia Urban Area in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), SAS_NW.Upola=recruitment census region of Northwest Upola in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), SAS_rest.Upola=recruitment census region including rest of Upola in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), SAS_Savaii=recruitment census region of Savaii in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), WHI_Midwest=recruitment from Midwest region of the USA for WHI (Womens Health Initiative), WHI_Northeast=recruitment from Northeast region of the USA for WHI (Womens Health Initiative), WHI_South=recruitment from South region of the USA for WHI (Womens Health Initiative), WHI_West=recruitment from West region of the USA for WHI (Womens Health Initiative)"" (HARMONIZED)",ARIC SURVEILLANCE EVENT ID (CIR),23167,0.3306873
geographic_site,"""Site where the subject was recruted. ARIC_A=field center A representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), ARIC_B=field center B representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), ARIC_C=field center C representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), ARIC_D=field center D representing one of four anonymized centers (Forsyth County, NC, USA; Jackson, MS, USA; the northwest suburbs of Minneapolis, MN, USA; and Washington County, MD, USA) where baseline exam was conducted for ARIC (Atherosclerosis Risk in Communities), CARDIA_1=field center 1 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CARDIA_2=field center 2 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CARDIA_3=field center 3 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CARDIA_4=field center 4 representing one of four anonymized field centers (University of Alabama, Birmingham, AL, USA; Northwestern University, IL, USA; University of Minnesota, MN, USA; Kaiser Foundation Research Institute, Oakland, CA, USA) for subjects in the CARE project within CARDIA (Coronary Artery Risk Development in Young Adults), CHS_BOWMAN.GRAY=clinic at Bowman Gray University (Forsyth County, NC, USA) for CHS (Cardiovascular Health Study), CHS_DAVIS=clinic at Davis University (Sacramento County, CA, USA) for CHS (Cardiovascular Health Study), CHS_HOPKINS=clinic at Johns Hopkins University (Washington County, MD, USA) for CHS (Cardiovascular Health Study), CHS_PITT=clinic at University of Pittsburgh (Pittsburgh, PA, USA) for CHS (Cardiovascular Health Study), COPDGene_C01=clinical center C01 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C02=clinical center C02 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C03=clinical center C03 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C04=clinical center C04 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C05=clinical center C05 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C06=clinical center C06 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C07=clinical center C07 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C08=clinical center C08 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C09=clinical center C09 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C10=clinical center C10 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C11=clinical center C11 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C12=clinical center C12 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C13=clinical center C13 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C14=clinical center C14 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C15=clinical center C15 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C16=clinical center C16 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C17=clinical center C17 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C18=clinical center C18 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C19=clinical center C19 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C20=clinical center C20 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), COPDGene_C21=clinical center C21 representing one of 21 de-identified clinical centers for COPDGene (Genetic Epidemiology of COPD), GENOA_MN=recruitment from Rochester, MN, US, GENOA_MS=recruitment from Jackson, MS, US, GOLDN_MN=recruitment center at Minneapolis, MN, USA for GOLDN (Genetics of Lipid Lowering Drugs and Diet Network Lipodemics Study), GOLDN_UT=recruitment center at Salt Lake City, UT, USA for GOLDN (Genetics of Lipid Lowering Drugs and Diet Network Lipodemics Study), HCHS_SOL_Bronx=recruitment center Bronx, NY, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), HCHS_SOL_Chicago=recruitment center Chicago, IL, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), HCHS_SOL_Miami=recruitment center Miami, FL, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), HCHS_SOL_SanDiego=recruitment center San Diego, CA, USA for HCHS/SOL (Hispanic Community Health Study/Study of Latinos), JHS_Hinds=recruitment from urban and rural areas of Hinds county, MS, USA for JHS (Jackson Heart Study), JHS_Madison=recruitment from urban and rural areas of Madison county, MS, USA for JHS (Jackson Heart Study), JHS_Rankin=recruitment from urban and rural areas of Rankin county, MS, USA for JHS (Jackson Heart Study), JHS_Unknown=recruitment from unknown county in MS, USA for JHS (Jackson Heart Study), Mayo_VTE_Midwest_US=state of residence (at time of enrollment for Mayo_VTE study) is in the South region of the USA as defined by the Census Bureau, Mayo_VTE_Northeast_US=state of residence (at time of enrollment for Mayo_VTE study) is in the Northeast region of the USA as defined by the Census Bureau, Mayo_VTE_non_US=state of residence (at time of enrollment for Mayo_VTE study) is from a country outside the USA, Mayo_VTE_South_US=state of residence (at time of enrollment for Mayo_VTE study) is in the Midwest region of the USA as defined by the Census Bureau, Mayo_VTE_West_US=state of residence (at time of enrollment for Mayo_VTE study) is in the West region of the USA as defined by the Census Bureau, MESA_COL=field center/baseline clinic at Columbia University, NY, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_JHU=field center/baseline clinic at Johns Hopkins University, MD, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_NWU=field center/baseline clinic at Northwestern University, IL, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_UCLA=field center/baseline clinic at University of California, Los Angeles, CA, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_UMN=field center/baseline clinic at University of Minnesota, MN, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), MESA_WFU=field center/baseline clinic at Wake Forest University, NC, USA for MESA (Multi-Ethnic Study of Atherosclerosis Cohort), SAS_Apia.urban=recruitment census region of Apia Urban Area in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), SAS_NW.Upola=recruitment census region of Northwest Upola in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), SAS_rest.Upola=recruitment census region including rest of Upola in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), SAS_Savaii=recruitment census region of Savaii in Samoa for SAS (Genome-wide Association Study of Adiposity in Samoans), WHI_Midwest=recruitment from Midwest region of the USA for WHI (Womens Health Initiative), WHI_Northeast=recruitment from Northeast region of the USA for WHI (Womens Health Initiative), WHI_South=recruitment from South region of the USA for WHI (Womens Health Initiative), WHI_West=recruitment from West region of the USA for WHI (Womens Health Initiative)"" (HARMONIZED)",FRAMINGHAM HEART STUDY PARTICIPANT COHORT IDENTIFIER,100179,0.28051782
index_date,"""Indicates whether the time point reference begins at the donor's actual death, presumed death, or when the cross clamp was applied in the case of surgical donors.""",TIME OF DEATH,234515,0.6204491
index_date,"""Indicates whether the time point reference begins at the donor's actual death, presumed death, or when the cross clamp was applied in the case of surgical donors.""",DNR TIME (RELATIVE TO EDARTM),74013,0.46247303
index_date,"""Indicates whether the time point reference begins at the donor's actual death, presumed death, or when the cross clamp was applied in the case of surgical donors.""",TIME OF CLINICAL DEATH,234449,0.35655868
transplanted_organ,"If the Donor was an Organ Donor, which Organs were donated.",BONE MARROW DONOR,35699,0.44960406
transplanted_organ,"If the Donor was an Organ Donor, which Organs were donated.",WHAT ORGAN WAS TRANSPLANTED?,254733,0.26779097
transplanted_organ,"If the Donor was an Organ Donor, which Organs were donated.",BLOOD TYPE OF DONOR,34900,0.14535783
unit_geographic_site,"harmonization unit for site (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNIT HAS A MATCH [SITE'S OPINION],242996,0.9967523
unit_geographic_site,"harmonization unit for site (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNIT,242992,0.9775
unit_geographic_site,"harmonization unit for site (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",OBSERVATION UNIT,166998,0.96909106
cardiac_output,RV Cardiac output (l/min) (HARMONIZED),RV CARDIAC OUTPUT (ML/MIN),205079,0.9860443
cardiac_output,RV Cardiac output (l/min) (HARMONIZED),CARDIAC OUTPUT (L/MIN),42413,0.7856377
cardiac_output,RV Cardiac output (l/min) (HARMONIZED),MEASURED CARDIAC OUTPUT (L/MIN),144968,0.7412996
age_at_bmi_baseline,age at measurement of bmi (years) (HARMONIZED),AGE AT MEASUREMENT,16680,0.40574303
age_at_bmi_baseline,age at measurement of bmi (years) (HARMONIZED),ADULT 1 BMI AT YEAR 1,14898,0.28150436
age_at_bmi_baseline,age at measurement of bmi (years) (HARMONIZED),ADULT 4 BMI AT YEAR 1,15157,0.25219983
age_at_height_baseline,age at measurement of height_baseline (years) (HARMONIZED),AGE AT BASELINE (YEARS),16530,0.7701192
age_at_height_baseline,age at measurement of height_baseline (years) (HARMONIZED),STANDARDIZED AGE AT BASELINE,222980,0.744842
age_at_height_baseline,age at measurement of height_baseline (years) (HARMONIZED),AGE AT BASELINE,16529,0.68130285
age_at_index,"The subject's age (in years) on the reference or anchor date used during date obfuscation (HARMONIZED). If age is greater than 89 years, see 'age_at_index_gt89'.",SUBJECT AGE,226270,0.41472104
age_at_index,"The subject's age (in years) on the reference or anchor date used during date obfuscation (HARMONIZED). If age is greater than 89 years, see 'age_at_index_gt89'.",AGE OF SUBJECT,17285,0.40374315
age_at_index,"The subject's age (in years) on the reference or anchor date used during date obfuscation (HARMONIZED). If age is greater than 89 years, see 'age_at_index_gt89'.","AGE; AGE >89 CATEGORIZED AS "">89""",17616,0.13028543
age_at_index_gt89,Indicate whether the subject's age (in years) on the reference or anchor date used during date obfuscation (HARMONIZED) is greater than 89 years.,"AGE; AGE >89 CATEGORIZED AS "">89""",17616,0.8472108
age_at_index_gt89,Indicate whether the subject's age (in years) on the reference or anchor date used during date obfuscation (HARMONIZED) is greater than 89 years.,IS TRUE AGE GREATER THAN 89?,128269,0.55223787
age_at_index_gt89,Indicate whether the subject's age (in years) on the reference or anchor date used during date obfuscation (HARMONIZED) is greater than 89 years.,"AGE (YEARS) 17 = <18, 89 = >88",16399,0.263789
age_at_weight_baseline,age at measurement of weight_baseline (years) (HARMONIZED),AGE AT BASELINE (YEARS),16530,0.661595
age_at_weight_baseline,age at measurement of weight_baseline (years) (HARMONIZED),STANDARDIZED AGE AT BASELINE,222980,0.6438893
age_at_weight_baseline,age at measurement of weight_baseline (years) (HARMONIZED),AGE AT BASELINE,16529,0.5809465
annotated_sex,"Subject sex, as recorded by the study. (HARMONIZED)",SEX OF SUBJECT,211860,0.8147908
annotated_sex,"Subject sex, as recorded by the study. (HARMONIZED)",SUBJECTS SEX,226588,0.7243831
annotated_sex,"Subject sex, as recorded by the study. (HARMONIZED)",GENDER (RECORDED AND USED BY BLOCK),103087,0.15190639
bmi_baseline,Body mass index calculated at baseline. (kg/m^2) (HARMONIZED),BODY MASS INDEX AT BASELINE,35519,0.9860443
bmi_baseline,Body mass index calculated at baseline. (kg/m^2) (HARMONIZED),BASELINE BODY MASS INDEX (KG/M SQRD),31003,0.9757161
bmi_baseline,Body mass index calculated at baseline. (kg/m^2) (HARMONIZED),BODY MASS INDEX (KG/M^2),35505,0.89805347
ethnicity,"An individual's self-described social and cultural grouping, specifically whether an individual describes themselves as Hispanic or Latino (HARMONIZED). The provided values are based on the categories defined by the U.S. Office of Management and Business and used by the U.S. Census Bureau.",ETHNICITY - HISPANIC OR LATINO,83708,0.37616467
ethnicity,"An individual's self-described social and cultural grouping, specifically whether an individual describes themselves as Hispanic or Latino (HARMONIZED). The provided values are based on the categories defined by the U.S. Office of Management and Business and used by the U.S. Census Bureau.",ETHNICITY (HISPANIC OR LATINO),83705,0.34886694
ethnicity,"An individual's self-described social and cultural grouping, specifically whether an individual describes themselves as Hispanic or Latino (HARMONIZED). The provided values are based on the categories defined by the U.S. Office of Management and Business and used by the U.S. Census Bureau.",RACE/ETHNICITY: HISPANIC OR LATINO,193982,0.2979804
height_baseline,Body height at baseline. (cm) (HARMONIZED),BASELINE HEIGHT (CM),31275,0.9514138
height_baseline,Body height at baseline. (cm) (HARMONIZED),ADULT 1 HEIGHT (CM) AT BASELINE,14907,0.9449947
height_baseline,Body height at baseline. (cm) (HARMONIZED),ADULT 2 HEIGHT (CM) AT BASELINE,15021,0.9269676
hispanic_subgroup,classification of Hispanic/Latino background for Hispanic/Latino subjects where country or region of origin information is available (HARMONIZED),7-LEVEL RE-CLASSIFICATION OF HISPANIC/LATINO BACKGROUND,10011,0.88059187
hispanic_subgroup,classification of Hispanic/Latino background for Hispanic/Latino subjects where country or region of origin information is available (HARMONIZED),CROSS-CLASSIFICATION OF CENTER AND HISPANIC/LATINO BACKGROUND,55433,0.7164171
hispanic_subgroup,classification of Hispanic/Latino background for Hispanic/Latino subjects where country or region of origin information is available (HARMONIZED),"CROSS-CLASSIFICATION OF CENTER AND HISPANIC LATINO BACKGROUND, 45+ YEARS ONLY",55432,0.5832627
population,"CHB Han Chinese in Beijing, China EAS; JPT Japanese in Tokyo, Japan EAS; CHS Southern Han Chinese EAS; CDX Chinese Dai in Xishuangbanna, China EAS; KHV Kinh in Ho Chi Minh City, Vietnam EAS; CEU Utah Residents (CEPH) with Northern and Western European Ancestry EUR; TSI Toscani in Italia EUR; FIN Finnish in Finland EUR; GBR British in England and Scotland EUR; IBS Iberian Population in Spain EUR; YRI Yoruba in Ibadan, Nigeria AFR; LWK Luhya in Webuye, Kenya AFR; GWD Gambian in Western Divisions in the Gambia AFR; MSL Mende in Sierra Leone AFR; ESN Esan in Nigeria AFR; ASW Americans of African Ancestry in SW USA AFR; ACB African Caribbeans in Barbados AFR; MXL Mexican Ancestry from Los Angeles USA AMR; PUR Puerto Ricans from Puerto Rico AMR; CLM Colombians from Medellin, Colombia AMR; PEL Peruvians from Lima, Peru AMR; GIH Gujarati Indian from Houston, Texas SAS; PJL Punjabi from Lahore, Pakistan SAS; BEB Bengali from Bangladesh SAS; STU Sri Lankan Tamil from the UK SAS; ITU Indian Telugu from the UK","RACE/ETHNICITY: ASIAN, NAT AM SET TO OTHER (6)",193981,0.9652504
population,"CHB Han Chinese in Beijing, China EAS; JPT Japanese in Tokyo, Japan EAS; CHS Southern Han Chinese EAS; CDX Chinese Dai in Xishuangbanna, China EAS; KHV Kinh in Ho Chi Minh City, Vietnam EAS; CEU Utah Residents (CEPH) with Northern and Western European Ancestry EUR; TSI Toscani in Italia EUR; FIN Finnish in Finland EUR; GBR British in England and Scotland EUR; IBS Iberian Population in Spain EUR; YRI Yoruba in Ibadan, Nigeria AFR; LWK Luhya in Webuye, Kenya AFR; GWD Gambian in Western Divisions in the Gambia AFR; MSL Mende in Sierra Leone AFR; ESN Esan in Nigeria AFR; ASW Americans of African Ancestry in SW USA AFR; ACB African Caribbeans in Barbados AFR; MXL Mexican Ancestry from Los Angeles USA AMR; PUR Puerto Ricans from Puerto Rico AMR; CLM Colombians from Medellin, Colombia AMR; PEL Peruvians from Lima, Peru AMR; GIH Gujarati Indian from Houston, Texas SAS; PJL Punjabi from Lahore, Pakistan SAS; BEB Bengali from Bangladesh SAS; STU Sri Lankan Tamil from the UK SAS; ITU Indian Telugu from the UK",RACE/ETHNICITY: ASIAN,193980,0.9652504
population,"CHB Han Chinese in Beijing, China EAS; JPT Japanese in Tokyo, Japan EAS; CHS Southern Han Chinese EAS; CDX Chinese Dai in Xishuangbanna, China EAS; KHV Kinh in Ho Chi Minh City, Vietnam EAS; CEU Utah Residents (CEPH) with Northern and Western European Ancestry EUR; TSI Toscani in Italia EUR; FIN Finnish in Finland EUR; GBR British in England and Scotland EUR; IBS Iberian Population in Spain EUR; YRI Yoruba in Ibadan, Nigeria AFR; LWK Luhya in Webuye, Kenya AFR; GWD Gambian in Western Divisions in the Gambia AFR; MSL Mende in Sierra Leone AFR; ESN Esan in Nigeria AFR; ASW Americans of African Ancestry in SW USA AFR; ACB African Caribbeans in Barbados AFR; MXL Mexican Ancestry from Los Angeles USA AMR; PUR Puerto Ricans from Puerto Rico AMR; CLM Colombians from Medellin, Colombia AMR; PEL Peruvians from Lima, Peru AMR; GIH Gujarati Indian from Houston, Texas SAS; PJL Punjabi from Lahore, Pakistan SAS; BEB Bengali from Bangladesh SAS; STU Sri Lankan Tamil from the UK SAS; ITU Indian Telugu from the UK",PRE-HOSPITAL RACE/ETHNICITY: ASIAN,185451,0.95687664
race,"Harmonized race category of participant. Acceptable values: white,american indian or alaska native,black or african american,asian,native hawaiian or other pacific islander,hispanic,multiple,other,Unknown,not reported,not allowed to collect (HARMONIZED)",PARTICIPANT'S RACE (1=HISPANIC 2=ASIAN/PACIFIC ISLANDER 3=AFRICAN AMERICAN 4=CAUCASIAN 5=OTHER),177240,0.82290184
race,"Harmonized race category of participant. Acceptable values: white,american indian or alaska native,black or african american,asian,native hawaiian or other pacific islander,hispanic,multiple,other,Unknown,not reported,not allowed to collect (HARMONIZED)","RACE: AMERICAN INDIAN/ALASKAN NATIVE, ASIAN, OR NATIVE HAWAI'IAN/OTHER PACIFIC ISLANDER",193999,0.4029206
race,"Harmonized race category of participant. Acceptable values: white,american indian or alaska native,black or african american,asian,native hawaiian or other pacific islander,hispanic,multiple,other,Unknown,not reported,not allowed to collect (HARMONIZED)","RACE (1 WHITE, 2 BLACK, 3 AMER INDIAN/ALASKAN NATIVE, 4 ASIAN/PACIFIC ISLANDER)",193818,0.38856003
subcohort,"A distinct subgroup within a study, generally indicating subjects who share similar characteristics due to study design. Subjects may belong to only one subcohort. (HARMONIZED)",SUB-COHORT GROUP,226135,0.9468921
subcohort,"A distinct subgroup within a study, generally indicating subjects who share similar characteristics due to study design. Subjects may belong to only one subcohort. (HARMONIZED)",SUBGROUP,226252,0.82544905
subcohort,"A distinct subgroup within a study, generally indicating subjects who share similar characteristics due to study design. Subjects may belong to only one subcohort. (HARMONIZED)",STUDY COHORT,225347,0.761893
unit_annotated_sex,"harmonization unit for annotated_sex (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",OBSERVATION UNIT,166998,0.9743373
unit_annotated_sex,"harmonization unit for annotated_sex (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",PHENOTYPE,181522,0.96544635
unit_annotated_sex,"harmonization unit for annotated_sex (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS,243044,0.9649213
unit_bmi_baseline,"harmonization unit for bmi_baseline (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",BASELINE BODY MASS INDEX,31001,0.9904406
unit_bmi_baseline,"harmonization unit for bmi_baseline (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)","BMI (COMPUTED BY SC FROM METRIC UNITS) (FROM ANT02,ANT03) AT BASELINE",35268,0.9886244
unit_bmi_baseline,"harmonization unit for bmi_baseline (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)","BMI (COMPUTED BY SC FROM IMPERIAL UNITS) (FROM IEC05A,B AT BASELINE)",35264,0.98761624
unit_ethnicity,"harmonization unit for ethnicity (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",OBSERVATION UNIT,166998,0.9829547
unit_ethnicity,"harmonization unit for ethnicity (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS,243044,0.9824231
unit_ethnicity,"harmonization unit for ethnicity (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",2.F HOMOGENEITY,6683,0.98076576
unit_height_baseline,"harmonization unit for height_baseline (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HEIGHTUNIT,110384,0.9759464
unit_height_baseline,"harmonization unit for height_baseline (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HEIGHT (UNIT),110222,0.9743861
unit_height_baseline,"harmonization unit for height_baseline (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNIT OF MEASUREMENT,243002,0.92749476
unit_hispanic_subgroup,"harmonization unit for hispanic_subgroup (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HISPANIC ETHNICITY,112232,0.9947187
unit_hispanic_subgroup,"harmonization unit for hispanic_subgroup (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HISPANIC,112230,0.9935369
unit_hispanic_subgroup,"harmonization unit for hispanic_subgroup (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS,243044,0.9658352
unit_race,"harmonization unit for race (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",RACE (RECODED TO HARMONIZE RESPONSES ACROSS CENTERS),193857,0.9980657
unit_race,"harmonization unit for race (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",SUBJECT RACE,226484,0.9955316
unit_race,"harmonization unit for race (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",OBSERVATION UNIT,166998,0.98609793
unit_subcohort,"harmonization unit for subcohort (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",SUB-COHORT GROUP,226135,0.9991639
unit_subcohort,"harmonization unit for subcohort (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",COHORT,50402,0.99455196
unit_subcohort,"harmonization unit for subcohort (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS,243044,0.98747206
unit_weight_baseline,"harmonization unit for weight_baseline (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",WEIGHT (UNIT),253457,0.97354424
unit_weight_baseline,"harmonization unit for weight_baseline (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",WEIGHT UNITS,253773,0.95799094
unit_weight_baseline,"harmonization unit for weight_baseline (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",OBSERVATION UNIT,166998,0.9222025
weight,Body weight at baseline. (kg) (HARMONIZED).,WEIGHT (KG) AT BASELINE,253391,0.96628344
weight,Body weight at baseline. (kg) (HARMONIZED).,WEIGHT AT BASELINE (KG),253501,0.961678
weight,Body weight at baseline. (kg) (HARMONIZED).,BASELINE WEIGHT (KG),31737,0.9431385
weight_baseline,Body weight at baseline. (kg) (HARMONIZED),WEIGHT (KG) AT BASELINE,253391,0.9719925
weight_baseline,Body weight at baseline. (kg) (HARMONIZED),WEIGHT AT BASELINE (KG),253501,0.9644556
weight_baseline,Body weight at baseline. (kg) (HARMONIZED),BASELINE WEIGHT (KG),31737,0.95022655
age_at_basophil_ncnc_bld,age at measurement of basophil_ncnc_bld (years) (HARMONIZED),AGE AT MEASUREMENT,16680,0.15291561
age_at_basophil_ncnc_bld,age at measurement of basophil_ncnc_bld (years) (HARMONIZED),AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25),16681,0.07172112
age_at_basophil_ncnc_bld,age at measurement of basophil_ncnc_bld (years) (HARMONIZED),AGE AT BASELINE (YEARS),16530,0.05350215
age_at_eosinophil_ncnc_bld,age at measurement of eosinophil_ncnc_bld (years) (HARMONIZED),AGE AT MEASUREMENT,16680,0.09203286
age_at_eosinophil_ncnc_bld,age at measurement of eosinophil_ncnc_bld (years) (HARMONIZED),9E EOSINOPHILS (%),10711,0.027117657
age_at_eosinophil_ncnc_bld,age at measurement of eosinophil_ncnc_bld (years) (HARMONIZED),"TOTAL EOSINOPHIL COUNT, CELLS/MICROLITER",237142,0.025468083
age_at_hdl,age at measurement of hdl (years) (HARMONIZED),HDL CHOLESTEROL 6 YEARS,108735,0.7077078
age_at_hdl,age at measurement of hdl (years) (HARMONIZED),HDL CHOLESTEROL (MG/DL) AT YEAR 1,108717,0.46660253
age_at_hdl,age at measurement of hdl (years) (HARMONIZED),HDL CHOLESTEROL (MG/DL) AT YEAR 2,108718,0.4434799
age_at_hematocrit_vfr_bld,"Measurement of hematocrit, the fraction of volume (vfr) of blood (bld) that is composed of red blood cells. (years) (HARMONIZED)",HEMATOCRIT (% RED BLOOD CELLS IN WHOLE BLOOD),110470,0.87976795
age_at_hematocrit_vfr_bld,"Measurement of hematocrit, the fraction of volume (vfr) of blood (bld) that is composed of red blood cells. (years) (HARMONIZED)",BLOOD ANALYSIS: HEMATOCRIT,34250,0.85800624
age_at_hematocrit_vfr_bld,"Measurement of hematocrit, the fraction of volume (vfr) of blood (bld) that is composed of red blood cells. (years) (HARMONIZED)",HEMATOCRIT (HCT %),110481,0.8458151
age_at_hemoglobin_mcnc_bld,age at measurement of hemoglobin_mcnc_bld. (years) (HARMONIZED),AGE AT MEASUREMENT,16680,0.16762705
age_at_hemoglobin_mcnc_bld,age at measurement of hemoglobin_mcnc_bld. (years) (HARMONIZED),DAYS TO DATE OF HGB MEASUREMENT,66283,0.12485182
age_at_hemoglobin_mcnc_bld,age at measurement of hemoglobin_mcnc_bld. (years) (HARMONIZED),AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25),16681,0.07751766
age_at_ldl,age at measurement of ldl (years) (HARMONIZED),LDL CHOLESTEROL 6 YEARS,131933,0.6884684
age_at_ldl,age at measurement of ldl (years) (HARMONIZED),LDL-CHOLESTEROL (DERIVED) (MG/DL) AT YEAR 3,131973,0.53913486
age_at_ldl,age at measurement of ldl (years) (HARMONIZED),LDL-CHOLESTEROL (DERIVED) (MG/DL) AT YEAR 1,131971,0.48751327
age_at_lymphocyte_ncnc_bld,age at measurement of lymphocyte_ncnc_bld (years) (HARMONIZED),AGE AT BLOOD OR LYMPH CANCER,16534,0.035144847
age_at_lymphocyte_ncnc_bld,age at measurement of lymphocyte_ncnc_bld (years) (HARMONIZED),DATE OF LYMPHOCYTE COUNT (DATE TO DAYS),61268,0.031084951
age_at_lymphocyte_ncnc_bld,age at measurement of lymphocyte_ncnc_bld (years) (HARMONIZED),DAYS FROM RANDOMIZATION TO DATE OF LYMPHOCYTE COUNT,64945,0.01302049
age_at_mch_entmass_rbc,age at measurement of mch_entmass_rbc (years) (HARMONIZED),AGE AT MEASUREMENT,16680,0.19042274
age_at_mch_entmass_rbc,age at measurement of mch_entmass_rbc (years) (HARMONIZED),UNITS - MCHC,243063,0.1261379
age_at_mch_entmass_rbc,age at measurement of mch_entmass_rbc (years) (HARMONIZED),AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25),16681,0.086632065
age_at_mchc_mcnc_rbc,age at measurement of mchc_mcnc_rbc (years) (HARMONIZED),UNITS - MCHC,243063,0.22236222
age_at_mchc_mcnc_rbc,age at measurement of mchc_mcnc_rbc (years) (HARMONIZED),AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25),16681,0.15752527
age_at_mchc_mcnc_rbc,age at measurement of mchc_mcnc_rbc (years) (HARMONIZED),MCHC,142506,0.12527926
age_at_mcv_entvol_rbc,age at measurement of mcv_entvol_rbc (years) (HARMONIZED),MCV,142587,0.16559312
age_at_mcv_entvol_rbc,age at measurement of mcv_entvol_rbc (years) (HARMONIZED),AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25),16681,0.104660206
age_at_mcv_entvol_rbc,age at measurement of mcv_entvol_rbc (years) (HARMONIZED),MEAN CELL VOLUME (MCV),143075,0.07793769
age_at_monocyte_ncnc_bld,age at measurement of monocyte_ncnc_bld (years) (HARMONIZED),AGE AT MEASUREMENT,16680,0.23144047
age_at_monocyte_ncnc_bld,age at measurement of monocyte_ncnc_bld (years) (HARMONIZED),AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25),16681,0.1328517
age_at_monocyte_ncnc_bld,age at measurement of monocyte_ncnc_bld (years) (HARMONIZED),CD34P_AC133P_B1 PERIPHERAL BLOOD MEASURE AT BASELINE,44029,0.041230027
age_at_neutrophil_ncnc_bld,age at measurement of neutrophil_ncnc_bld (years) (HARMONIZED),AGE AT MEASUREMENT,16680,0.13788034
age_at_neutrophil_ncnc_bld,age at measurement of neutrophil_ncnc_bld (years) (HARMONIZED),ABSOLUTE NEUTROPHIL COUNT (ANC),12042,0.0921962
age_at_neutrophil_ncnc_bld,age at measurement of neutrophil_ncnc_bld (years) (HARMONIZED),II_3B ABSOLUTE NEUTROPHIL COUNT (ANC),121311,0.08093671
age_at_platelet_ncnc_bld,age at measurement of platelet_ncnc_bld (years) (HARMONIZED),DAYS TO DATE OF PLATELETS MEASUREMENT,66303,0.29421496
age_at_platelet_ncnc_bld,age at measurement of platelet_ncnc_bld (years) (HARMONIZED),AGE (YRS) RECVD A TRANSFUSION OF PLATELE,16419,0.28866935
age_at_platelet_ncnc_bld,age at measurement of platelet_ncnc_bld (years) (HARMONIZED),AGE AT MEASUREMENT,16680,0.17981844
age_at_pmv_entvol_bld,age at measurement of pmv_entvol_bld (years) (HARMONIZED),AGE AT MEASUREMENT,16680,0.19961987
age_at_pmv_entvol_bld,age at measurement of pmv_entvol_bld (years) (HARMONIZED),AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25),16681,0.12940273
age_at_pmv_entvol_bld,age at measurement of pmv_entvol_bld (years) (HARMONIZED),YEAR OF MEASUREMENT,258930,0.034880888
age_at_rbc_ncnc_bld,age at measurement of rbc_ncnc_bld (years) (HARMONIZED),AGE AT MEASUREMENT,16680,0.23335676
age_at_rbc_ncnc_bld,age at measurement of rbc_ncnc_bld (years) (HARMONIZED),AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25),16681,0.10248422
age_at_rbc_ncnc_bld,age at measurement of rbc_ncnc_bld (years) (HARMONIZED),RE91: B3A. AGE OF RBC PRODUCT,196115,0.06064055
age_at_rdw_ratio_rbc,age at measurement of rdw_ratio_rbc (years) (HARMONIZED),RDW (%),195309,0.20625381
age_at_rdw_ratio_rbc,age at measurement of rdw_ratio_rbc (years) (HARMONIZED),AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25),16681,0.09170696
age_at_rdw_ratio_rbc,age at measurement of rdw_ratio_rbc (years) (HARMONIZED),RED CELL DISTRIBUTION WIDTH (RDW) (%),199505,0.05997644
age_at_total_cholesterol,age at measurement of total_cholesterol (years) (HARMONIZED),TOTAL CHOLESTEROL 6 YEARS,236863,0.5590192
age_at_total_cholesterol,age at measurement of total_cholesterol (years) (HARMONIZED),TOTAL CHOLESTEROL (MG/DL) AT YEAR 1,236845,0.5074343
age_at_total_cholesterol,age at measurement of total_cholesterol (years) (HARMONIZED),TOTAL CHOLESTEROL 2 YEARS,236861,0.40309682
age_at_triglycerides,age at measurement of triglycerides (HARMONIZED),AGE AT LIPID DETERMINATION,16674,0.2007143
age_at_triglycerides,age at measurement of triglycerides (HARMONIZED),AGE AT MEASUREMENT,16680,0.13986565
age_at_triglycerides,age at measurement of triglycerides (HARMONIZED),FASTING TRIGLYCERIDES (MG/DL),92884,0.013480103
age_at_wbc_ncnc_bld,age at measurement of wbc_ncnc_bld (years) (HARMONIZED),AGE AT MEASUREMENT,16680,0.20577459
age_at_wbc_ncnc_bld,age at measurement of wbc_ncnc_bld (years) (HARMONIZED),DATE OF WBC (DATE TO DAYS),61848,0.10932483
age_at_wbc_ncnc_bld,age at measurement of wbc_ncnc_bld (years) (HARMONIZED),AGE AT MEASUREMENT (MBCA2-DSRA4)/365.25),16681,0.0946777
basophil_ncnc_bld,"Count by volume, or number concentration (ncnc), of basophils in the blood (bld). (thousands / microliter) (HARMONIZED)","WHITE BLOOD COUNT, THOUSANDS PER MICROLITER",256039,0.5681163
basophil_ncnc_bld,"Count by volume, or number concentration (ncnc), of basophils in the blood (bld). (thousands / microliter) (HARMONIZED)",WHITE BLOOD CELL COUNT (X10/L),256004,0.18300885
basophil_ncnc_bld,"Count by volume, or number concentration (ncnc), of basophils in the blood (bld). (thousands / microliter) (HARMONIZED)",WHITE BLOOD CELL COUNT,255992,0.14928317
eosinophil_ncnc_bld,"Count by volume, or number concentration (ncnc), of eosinophils in the blood (bld). (thousands / microliter) (HARMONIZED)",EOSINOPHIL COUNT (X10^3/UL),82891,0.59819484
eosinophil_ncnc_bld,"Count by volume, or number concentration (ncnc), of eosinophils in the blood (bld). (thousands / microliter) (HARMONIZED)",CBC WITH DIFFERENTIAL CELL COUNT: EOSINOPHILS (ABSOLUTE COUNT) (0-9999/UL),43565,0.5467079
eosinophil_ncnc_bld,"Count by volume, or number concentration (ncnc), of eosinophils in the blood (bld). (thousands / microliter) (HARMONIZED)","TOTAL EOSINOPHIL COUNT, CELLS/MICROLITER",237142,0.26038945
hdl,Hdl cholesterol (mg/dl) (HARMONIZED),HDL-CHOLESTEROL (MG/DL),108809,0.65301627
hdl,Hdl cholesterol (mg/dl) (HARMONIZED),HDL-C CHOLESTEROL (MG/DL),108807,0.6237207
hdl,Hdl cholesterol (mg/dl) (HARMONIZED),TOTAL HDL CHOLESTEROL (MG/DL),237299,0.5718264
hematocrit_vfr_bld,"Measurement of hematocrit, the fraction of volume (vfr) of blood (bld) that is composed of red blood cells. (percentage) (HARMONIZED)",HEMATOCRIT (% RED BLOOD CELLS IN WHOLE BLOOD),110470,0.9404625
hematocrit_vfr_bld,"Measurement of hematocrit, the fraction of volume (vfr) of blood (bld) that is composed of red blood cells. (percentage) (HARMONIZED)",BLOOD ANALYSIS: HEMATOCRIT,34250,0.9206471
hematocrit_vfr_bld,"Measurement of hematocrit, the fraction of volume (vfr) of blood (bld) that is composed of red blood cells. (percentage) (HARMONIZED)",HEMATOCRIT (HCT) (%),110482,0.90397453
hemoglobin_mcnc_bld,"Measurement of mass per volume, or mass concentration (mcnc), of hemoglobin in the blood (bld). (g / dL = grams per deciliter) (HARMONIZED)","MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION, MCHC (G/DL)",143100,0.9418684
hemoglobin_mcnc_bld,"Measurement of mass per volume, or mass concentration (mcnc), of hemoglobin in the blood (bld). (g / dL = grams per deciliter) (HARMONIZED)",MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION (MCHC) (G/DL),143098,0.81626
hemoglobin_mcnc_bld,"Measurement of mass per volume, or mass concentration (mcnc), of hemoglobin in the blood (bld). (g / dL = grams per deciliter) (HARMONIZED)",MEAN CELLULAR HEMOGLOBIN CONCENTRATION(GM/DL),143077,0.755637
ldl,Ldl cholesterol (mg/dl) (HARMONIZED),LDL CHOLESTEROL CALCULATED (MG/DL),131935,0.91165274
ldl,Ldl cholesterol (mg/dl) (HARMONIZED),LDL CHOLESTEROL (MG/DL),131927,0.9092645
ldl,Ldl cholesterol (mg/dl) (HARMONIZED),LDL-CHOLESTEROL (MG/DL),131974,0.8929365
lymphocyte_ncnc_bld,"Count by volume, or number concentration (ncnc), of lymphocytes in the blood (bld). (thousands / microliter) (HARMONIZED)",LYMPHOCYTE COUNT (X10^3/UL),140055,0.12474515
lymphocyte_ncnc_bld,"Count by volume, or number concentration (ncnc), of lymphocytes in the blood (bld). (thousands / microliter) (HARMONIZED)",LYMPHOCYTE COUNT,140052,0.10266401
lymphocyte_ncnc_bld,"Count by volume, or number concentration (ncnc), of lymphocytes in the blood (bld). (thousands / microliter) (HARMONIZED)",LYMPHOCYTE COUNT (X10E9),140053,0.09186978
mch_entmass_rbc,"Measurement of the average mass (entmass) of hemoglobin per red blood cell(rbc), known as mean corpuscular hemoglobin (MCH). (pg = picogram) (HARMONIZED)",MEAN CORPUSCULAR HEMOGLOBIN (MCH) (PG),143090,0.9863632
mch_entmass_rbc,"Measurement of the average mass (entmass) of hemoglobin per red blood cell(rbc), known as mean corpuscular hemoglobin (MCH). (pg = picogram) (HARMONIZED)","MEAN CORPUSCULAR HEMOGLOBIN, MCH (PG)",143101,0.98538435
mch_entmass_rbc,"Measurement of the average mass (entmass) of hemoglobin per red blood cell(rbc), known as mean corpuscular hemoglobin (MCH). (pg = picogram) (HARMONIZED)","MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION, MCHC (G/DL)",143100,0.9481545
mchc_mcnc_rbc,"Measurement of the mass concentration (mcnc) of hemoglobin in a given volume of packed red blood cells (rbc), known as mean corpuscular hemoglobin concentration (MCHC). (g /dL = grams per deciliter) (HARMONIZED)",MCHC - MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION - NUMERIC VALUE G/DL,142510,0.98926485
mchc_mcnc_rbc,"Measurement of the mass concentration (mcnc) of hemoglobin in a given volume of packed red blood cells (rbc), known as mean corpuscular hemoglobin concentration (MCHC). (g /dL = grams per deciliter) (HARMONIZED)",CHCM (G/DL) - MEAN OF THE RBC HGB CONCENTRATION,45928,0.9854964
mchc_mcnc_rbc,"Measurement of the mass concentration (mcnc) of hemoglobin in a given volume of packed red blood cells (rbc), known as mean corpuscular hemoglobin concentration (MCHC). (g /dL = grams per deciliter) (HARMONIZED)","MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION, MCHC (G/DL)",143100,0.98141783
mcv_entvol_rbc,"Measurement of the mass concentration (mcnc) of hemoglobin in a given volume of packed red blood cells (rbc), known as mean corpuscular hemoglobin concentration (MCHC). (g /dL = grams per deciliter) (HARMONIZED)",MCHC - MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION - NUMERIC VALUE G/DL,142510,0.98926485
mcv_entvol_rbc,"Measurement of the mass concentration (mcnc) of hemoglobin in a given volume of packed red blood cells (rbc), known as mean corpuscular hemoglobin concentration (MCHC). (g /dL = grams per deciliter) (HARMONIZED)",CHCM (G/DL) - MEAN OF THE RBC HGB CONCENTRATION,45928,0.9854964
mcv_entvol_rbc,"Measurement of the mass concentration (mcnc) of hemoglobin in a given volume of packed red blood cells (rbc), known as mean corpuscular hemoglobin concentration (MCHC). (g /dL = grams per deciliter) (HARMONIZED)","MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION, MCHC (G/DL)",143100,0.98141783
monocyte_ncnc_bld,"Count by volume, or number concentration (ncnc), of monocytes in the blood (bld). (HARMONIZED)",MONOCYTE COUNT,152746,0.4499968
monocyte_ncnc_bld,"Count by volume, or number concentration (ncnc), of monocytes in the blood (bld). (HARMONIZED)",WHITE BLOOD CELL COUNT,255992,0.23005374
monocyte_ncnc_bld,"Count by volume, or number concentration (ncnc), of monocytes in the blood (bld). (HARMONIZED)",WHITE BLOOD CELL COUNT (MM3),256002,0.22422527
neutrophil_ncnc_bld,"Count by volume, or number concentration (ncnc), of neutrophils in the blood (bld). (HARMONIZED)",NEUTROPHIL COUNT (ANC),157930,0.33709443
neutrophil_ncnc_bld,"Count by volume, or number concentration (ncnc), of neutrophils in the blood (bld). (HARMONIZED)",ABSOLUTE NEUTROPHIL COUNT (ANC),12042,0.33513322
neutrophil_ncnc_bld,"Count by volume, or number concentration (ncnc), of neutrophils in the blood (bld). (HARMONIZED)",II_3B ABSOLUTE NEUTROPHIL COUNT (ANC),121311,0.25608712
platelet_ncnc_bld,"Count by volume, or number concentration (ncnc), of platelets in the blood (bld). (thousands / microliter) (HARMONIZED)","PLATELET COUNT, THOUSANDS PER MICROLITER",183333,0.95506835
platelet_ncnc_bld,"Count by volume, or number concentration (ncnc), of platelets in the blood (bld). (thousands / microliter) (HARMONIZED)",PLATELET COUNT (1000/MM3),183280,0.9361684
platelet_ncnc_bld,"Count by volume, or number concentration (ncnc), of platelets in the blood (bld). (thousands / microliter) (HARMONIZED)",PLATELET COUNT (10^9/L),183283,0.8690492
pmv_entvol_bld,"Measurement of the mean volume (entvol) of platelets in the blood (bld), known as mean platelet volume (MPV or PMV). (fL = femtoliter) (HARMONIZED)",MPV - MEAN PLATELET VOLUME - NUMERIC VALUE FL,154727,0.9881766
pmv_entvol_bld,"Measurement of the mean volume (entvol) of platelets in the blood (bld), known as mean platelet volume (MPV or PMV). (fL = femtoliter) (HARMONIZED)","MEAN PLATELET VOLUME, MPV (ΜM3)",144603,0.98072886
pmv_entvol_bld,"Measurement of the mean volume (entvol) of platelets in the blood (bld), known as mean platelet volume (MPV or PMV). (fL = femtoliter) (HARMONIZED)",MEAN PLATELET VOLUME (FL),144601,0.9757161
rbc_ncnc_bld,"Count by volume, or number concentration (ncnc), of red blood cells in the blood (bld). (millions / microliter) (HARMONIZED)","RED BLOOD COUNT, MILLIONS PER MICROLITER",199494,0.9666632
rbc_ncnc_bld,"Count by volume, or number concentration (ncnc), of red blood cells in the blood (bld). (millions / microliter) (HARMONIZED)",RED BLOOD CELL COUNT,199474,0.8767399
rbc_ncnc_bld,"Count by volume, or number concentration (ncnc), of red blood cells in the blood (bld). (millions / microliter) (HARMONIZED)",RED BLOOD CELL COUNT (MILLIONS CELLS/UL),199478,0.8715842
rdw_ratio_rbc,"Measurement of the ratio of variation in width to the mean width of the red blood cell (rbc) volume distribution curve taken at +/- 1 CV, known as red cell distribution width (RDW). (percentage) (HARMONIZED)",RDW - RED CELL DISTRIBUTION WIDTH - NUMERIC VALUE %,195310,0.99351174
rdw_ratio_rbc,"Measurement of the ratio of variation in width to the mean width of the red blood cell (rbc) volume distribution curve taken at +/- 1 CV, known as red cell distribution width (RDW). (percentage) (HARMONIZED)",RED CELL DISTRIBUTION WIDTH (RDW) (%),199505,0.99010193
rdw_ratio_rbc,"Measurement of the ratio of variation in width to the mean width of the red blood cell (rbc) volume distribution curve taken at +/- 1 CV, known as red cell distribution width (RDW). (percentage) (HARMONIZED)","RED CELL DISTRIBUTION WIDTH, RDW (%)",199507,0.9896718
total_cholesterol,Total cholesterol (mg/dl) (HARMONIZED),TOTAL CHOLESTEROL (MG/DL),236841,0.9360516
total_cholesterol,Total cholesterol (mg/dl) (HARMONIZED),TOTAL CHOLESTEROL (MG-DL),236839,0.9136765
total_cholesterol,Total cholesterol (mg/dl) (HARMONIZED),TOTAL HDL CHOLESTEROL (MG/DL),237299,0.84221536
triglycerides,Triglycerides (mg/dl) (HARMONIZED),TOTAL TRIGLYCERIDES (MG/DL),238621,0.5616356
triglycerides,Triglycerides (mg/dl) (HARMONIZED),TOTAL TRIGLYCERIDES (MG-DL),238620,0.5201764
triglycerides,Triglycerides (mg/dl) (HARMONIZED),NON-FASTING TRIGLYCERIDES (MG/DL),160094,0.3599264
unit_basophil_ncnc_bld,"harmonization unit for basophil_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HYPERSEGMENTED NEUTROPHILS (LABA63),117756,0.97813547
unit_basophil_ncnc_bld,"harmonization unit for basophil_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",OBSERVATION UNIT,166998,0.97399324
unit_basophil_ncnc_bld,"harmonization unit for basophil_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",PROCALCITONIN UNIT,187463,0.9642542
unit_eosinophil_ncnc_bld,"harmonization unit for eosinophil_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",OBSERVATION UNIT,166998,0.95195264
unit_eosinophil_ncnc_bld,"harmonization unit for eosinophil_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HYPERSEGMENTED NEUTROPHILS (LABA63),117756,0.9452985
unit_eosinophil_ncnc_bld,"harmonization unit for eosinophil_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",PROCALCITONIN UNIT,187463,0.9417614
unit_hdl,"harmonization unit for hdl (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",C_HDL,57197,0.99720997
unit_hdl,"harmonization unit for hdl (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",LN(HDL),136423,0.99703056
unit_hdl,"harmonization unit for hdl (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HEMOGLOBIN UNIT,110764,0.99554896
unit_hematocrit_vfr_bld,"harmonization unit for hematocrit_vfr_bld. (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HEMATOCRIT UNIT,110516,0.99716616
unit_hematocrit_vfr_bld,"harmonization unit for hematocrit_vfr_bld. (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - HCT,243059,0.9867261
unit_hematocrit_vfr_bld,"harmonization unit for hematocrit_vfr_bld. (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HAEMOGLOBIN UNIT,105983,0.98255754
unit_hemoglobin_mcnc_bld,"Measurement of hematocrit, the fraction of volume (vfr) of blood (bld) that is composed of red blood cells. (percentage) (HARMONIZED)",HEMATOCRIT (% RED BLOOD CELLS IN WHOLE BLOOD),110470,0.9404625
unit_hemoglobin_mcnc_bld,"Measurement of hematocrit, the fraction of volume (vfr) of blood (bld) that is composed of red blood cells. (percentage) (HARMONIZED)",BLOOD ANALYSIS: HEMATOCRIT,34250,0.9206471
unit_hemoglobin_mcnc_bld,"Measurement of hematocrit, the fraction of volume (vfr) of blood (bld) that is composed of red blood cells. (percentage) (HARMONIZED)",HEMATOCRIT (HCT) (%),110482,0.90397453
unit_ldl,"harmonization unit for ldl (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",LDH UNIT,131898,0.9847524
unit_ldl,"harmonization unit for ldl (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)","UNITS FOR LDH2:A=U/L,B=%)",243078,0.97850823
unit_ldl,"harmonization unit for ldl (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",TOTAL CHOLESTEROL UNIT,236879,0.97046465
unit_lymphocyte_ncnc_bld,"harmonization unit for lymphocyte_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",WBC UNIT,251820,0.99424744
unit_lymphocyte_ncnc_bld,"harmonization unit for lymphocyte_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",LYMPHOCYTE (10^3/UL) [7/15/95],140050,0.98742366
unit_lymphocyte_ncnc_bld,"harmonization unit for lymphocyte_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",# HLA MATCHED UNITS,348,0.98191
unit_mch_entmass_rbc,"harmonization unit for mch_entmass_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - MCHC,243063,0.9963783
unit_mch_entmass_rbc,"harmonization unit for mch_entmass_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - RBC,243068,0.9961755
unit_mch_entmass_rbc,"harmonization unit for mch_entmass_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - MCH,243062,0.99586606
unit_mchc_mcnc_rbc,"harmonization unit for mchc_mcnc_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - MCHC,243063,0.9980277
unit_mchc_mcnc_rbc,"harmonization unit for mchc_mcnc_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - MCH,243062,0.99703056
unit_mchc_mcnc_rbc,"harmonization unit for mchc_mcnc_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",MCHC UNIT,142516,0.99648935
unit_mcv_entvol_rbc,"harmonization unit for mcv_entvol_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - MCHC,243063,0.9972531
unit_mcv_entvol_rbc,"harmonization unit for mcv_entvol_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - RBC,243068,0.99708784
unit_mcv_entvol_rbc,"harmonization unit for mcv_entvol_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",MCHC UNIT,142516,0.9957684
unit_monocyte_ncnc_bld,"harmonization unit for monocyte_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",WBC UNIT,251820,0.9953544
unit_monocyte_ncnc_bld,"harmonization unit for monocyte_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",MCHC UNIT,142516,0.98131067
unit_monocyte_ncnc_bld,"harmonization unit for monocyte_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",# HLA MATCHED UNITS,348,0.9801293
unit_neutrophil_ncnc_bld,"harmonization unit for neutrophil_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",WBC UNIT,251820,0.9947392
unit_neutrophil_ncnc_bld,"harmonization unit for neutrophil_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - WBC,243072,0.99411184
unit_neutrophil_ncnc_bld,"harmonization unit for neutrophil_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HYPERSEGMENTED NEUTROPHILS (LABA63),117756,0.97150993
unit_platelet_ncnc_bld,"harmonization unit for platelet_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",PLATELETS UNIT,183488,0.9962492
unit_platelet_ncnc_bld,"harmonization unit for platelet_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",PLATELETS UNITS,183489,0.99556625
unit_platelet_ncnc_bld,"harmonization unit for platelet_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",PATIENT'S PLATELET PHENOTYPE,178508,0.99408895
unit_pmv_entvol_bld,"harmonization unit for pmv_entvol_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - MPV,243066,0.99619037
unit_pmv_entvol_bld,"harmonization unit for pmv_entvol_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS,243044,0.97706646
unit_pmv_entvol_bld,"harmonization unit for pmv_entvol_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",OBSERVATION UNIT,166998,0.97666925
unit_rbc_ncnc_bld,"harmonization unit for rbc_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - RBC,243068,0.99815416
unit_rbc_ncnc_bld,"harmonization unit for rbc_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",B4. ABO GROUP OF RBC UNIT,30085,0.9963783
unit_rbc_ncnc_bld,"harmonization unit for rbc_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",NUCLEATED RBCS,161411,0.9927672
unit_rdw_ratio_rbc,"harmonization unit for rdw_ratio_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - RDW,243069,0.99592984
unit_rdw_ratio_rbc,"harmonization unit for rdw_ratio_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - RBC,243068,0.98942953
unit_rdw_ratio_rbc,"harmonization unit for rdw_ratio_rbc (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HEMATOLOGY RBC SI UNITS,110561,0.9705206
unit_total_cholesterol,"harmonization unit for total_cholesterol (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",TOTAL CHOLESTEROL UNIT,236879,0.9938549
unit_total_cholesterol,"harmonization unit for total_cholesterol (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",TOTAL CHOLESTEROL UNITS,236880,0.9917484
unit_total_cholesterol,"harmonization unit for total_cholesterol (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",TOTAL CHOLESTEROL.,236912,0.99135584
unit_triglycerides,"harmonization unit for triglycerides (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",TRIGLYCERIDES IN SI UNITS,240630,0.9762653
unit_triglycerides,"harmonization unit for triglycerides (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",TOTAL CHOLESTEROL UNIT,236879,0.9683214
unit_triglycerides,"harmonization unit for triglycerides (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",TOTAL CHOLESTEROL UNITS,236880,0.9596866
unit_wbc_ncnc_bld,"harmonization unit for wbc_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS - WBC,243072,0.9983451
unit_wbc_ncnc_bld,"harmonization unit for wbc_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",WBC UNIT,251820,0.9974689
unit_wbc_ncnc_bld,"harmonization unit for wbc_ncnc_bld (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",MCHC UNIT,142516,0.98761624
wbc_ncnc_bld,"Count by volume, or number concentration (ncnc), of white blood cells in the blood (bld). (thousands / microliter) (HARMONIZED)","WHITE BLOOD COUNT, THOUSANDS PER MICROLITER",256039,0.95877
wbc_ncnc_bld,"Count by volume, or number concentration (ncnc), of white blood cells in the blood (bld). (thousands / microliter) (HARMONIZED)",WHITE BLOOD CELL COUNT,255992,0.8822251
wbc_ncnc_bld,"Count by volume, or number concentration (ncnc), of white blood cells in the blood (bld). (thousands / microliter) (HARMONIZED)",TOTAL WHITE BLOOD COUNT (WBC X 1000),239224,0.831143
age_at_antihypertensive_meds,age at measurement of antihypertensive_meds (years) (HARMONIZED),"HYPERTENSION MEDS, AGE STARTED USE",117820,0.22337706
age_at_antihypertensive_meds,age at measurement of antihypertensive_meds (years) (HARMONIZED),HYPERTENSION (AGE),117769,0.12189466
age_at_antihypertensive_meds,age at measurement of antihypertensive_meds (years) (HARMONIZED),AGE HYPERTENSION,17076,0.09434341
age_at_fasting_lipids,age at measurement of fasting_lipids (years) (HARMONIZED),AGE AT DIAGNOSIS (YRS) - LIPIDS,16569,0.66974485
age_at_fasting_lipids,age at measurement of fasting_lipids (years) (HARMONIZED),AGE AT LIPID DETERMINATION,16674,0.32584226
age_at_fasting_lipids,age at measurement of fasting_lipids (years) (HARMONIZED),FASTING: TOTAL CHOLESTEROL,92892,0.078078166
age_at_lipid_lowering_medication,age at measurement of age_at_lipid1c (years) (HARMONIZED),AGE AT DIAGNOSIS (YRS) - LIPIDS,16569,0.6579781
age_at_lipid_lowering_medication,age at measurement of age_at_lipid1c (years) (HARMONIZED),AGE AT LIPID DETERMINATION,16674,0.32852945
age_at_lipid_lowering_medication,age at measurement of age_at_lipid1c (years) (HARMONIZED),TOTAL CHOLESTEROL (MG/DL) AT YEAR 1,236845,0.04401865
antihypertensive_meds,Indicator for use of antihypertensive medication at the time of blood pressure measurement. (HARMONIZED),HISTORY OF HYPERTENSION INDICATOR,112509,0.761893
antihypertensive_meds,Indicator for use of antihypertensive medication at the time of blood pressure measurement. (HARMONIZED),"SYSTOLIC BLOOD PRESSURE, READING #1 AT WITHDRAW DATE OF ANTIHYPERTENSIVE MEDICATION",229129,0.38462317
antihypertensive_meds,Indicator for use of antihypertensive medication at the time of blood pressure measurement. (HARMONIZED),HOUR OF TIME OF BLOOD PRESSURE MEASUREMENT,114107,0.31195062
fasting_lipids,Indicates whether participant fasted for at least eight hours prior to blood draw to measure lipids phenotypes. (HARMONIZED),DID SUBJECT FAST PRIOR TO LIPID COLLECTION?,70874,0.83223665
fasting_lipids,Indicates whether participant fasted for at least eight hours prior to blood draw to measure lipids phenotypes. (HARMONIZED),FASTING TIME OF 8 HOURS OR MORE,92879,0.46377817
fasting_lipids,Indicates whether participant fasted for at least eight hours prior to blood draw to measure lipids phenotypes. (HARMONIZED),V5 FASTING TIME OF 8 HOURS OR MORE,245083,0.40739235
hypertension_meds,Take medication for hypertension (HARMONIZED),MEDICATION FOR HIGH BP/HYPERTENSION,146554,0.6078378
hypertension_meds,Take medication for hypertension (HARMONIZED),HYPERTENSION MEDICATION,117816,0.46198756
hypertension_meds,Take medication for hypertension (HARMONIZED),REGULAR MEDICATION FOR HYPERTENSION,199960,0.36240488
lipid_lowering_medication,Any lipid-lowering medication (HARMONIZED),ANY LIPID-LOWERING MEDICATION,21559,0.86511016
lipid_lowering_medication,Any lipid-lowering medication (HARMONIZED),LIPID LOWERING MEDS,135787,0.8044059
lipid_lowering_medication,Any lipid-lowering medication (HARMONIZED),HYPOLIPIDEMICS (LIPID LOWERING MEDS),117956,0.5307078
unit_antihypertensive_meds,"harmonization unit for antihypertensive_meds (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",MEDICATION UNIT,146894,0.9862577
unit_antihypertensive_meds,"harmonization unit for antihypertensive_meds (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS OF MEDICATION 7,243090,0.9805806
unit_antihypertensive_meds,"harmonization unit for antihypertensive_meds (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",UNITS OF MEDICATION 2,243085,0.9793541
unit_fasting_lipids,"harmonization unit for fasting_lipids (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)","FASTING LIPIDS, TRIGLYCERIDE",92857,0.9980582
unit_fasting_lipids,"harmonization unit for fasting_lipids (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HDL-1ST COMPLETE LIPIDS,108789,0.9916842
unit_fasting_lipids,"harmonization unit for fasting_lipids (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",TOTAL CHOLESTEROL UNIT,236879,0.9250947
unit_lipid_lowering_medication,"harmonization unit for unit_lipid1c (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",HDL-1ST COMPLETE LIPIDS,108789,0.99010193
unit_lipid_lowering_medication,"harmonization unit for unit_lipid1c (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",MCHC UNIT,142516,0.9360516
unit_lipid_lowering_medication,"harmonization unit for unit_lipid1c (A ""harmonization unit"" is a defined group of subjects whose phenotypes can be similarly processed.) (HARMONIZED)",TOTAL CHOLESTEROL UNIT,236879,0.91196686
